Long-term follow-up of subcutaneous versus intravenous bortezomib during induction therapy for newly diagnosed multiple myeloma treated within the GMMG-MM5 Phase III Trial
Related Research units
Bibliographical data
Original language | English |
---|---|
ISSN | 0887-6924 |
DOIs | |
Publication status | Published - 10.2021 |
PubMed | 34031532 |
---|